周三，BTIG对InMode Ltd. (NASDAQ: INMD)启动覆盖，给予买入评级，目标价为25.00美元。该公司强调InMode作为基于能量的微创手术美容治疗领先提供商的地位。尽管InMode在商业上取得了显著成功，2018年至2023年的复合年增长率(CAGR)约为38%，但其股票目前正在四年低点交易。这种下跌归因于美容资本设备和手术需求的最近收缩。 美容市场资本设备采购的下滑主要被视 ...

周三，BTIG对Apyx Medical Corp. (NASDAQ: APYX)启动覆盖，给予中性评级。该公司通过其Renuvion平台参与美容手术市场，该平台利用氦等离子体技术提供微创皮肤紧致解决方案。这种设备通常与脂肪吸引术配合使用，后者是美国和全球领先的外科美容手术。 Apyx Medical的Renuvion以超过90篇临床论文支持其在各种应用和治疗领域的安全性和有效性而脱颖而出。这一大 ...

Investors in exchange-traded funds tracking China stocks may be feeling some motion sickness after the country's stock market ...

BTIG：将医疗设备制造商 波士顿科学 的目标价从84美元上调至93美元，维持“买入”评级。 (格隆汇) ...

According to Ponzio, there is a wide range of the buy-side’s adoption of algorithms. Some use algorithms, but only manually, and don’t really measure performance, but instead use poor benchmarks like ...

U.S. stocks were suffering a modest setback Tuesday, but appeared to be merely taking a breather from a rally that's pushed the S&P 500 and Dow Jones Industrial Average to a round of records as ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 17.07% ...

We recently compiled a list of the 35 AI News You Should Not Miss. In this article, we are going to take a look at where ...

In 2018 and 2019, Expedia and Booking tilted toward stock buybacks worth $15.8 billion while combined they spent just $335 ...

智通财经APP获悉，周二，截至发稿，Affirm Holdings (AFRM.US)涨超6%，报41.09美元。BTIG分析师Vincent Caintic上调该股评级至“买入”，目标价68美元。

BTIG has upgraded buy now, pay later company Affirm (AFRM) to Buy from Neutral, citing its path to profitability. Meanwhile, ...

智通财经APP获悉，BTIG首席市场技术分析师Jonathan Krinsky在一份报告中称，追踪软件股表现的SPDR标普软件与服务ETF (XSW.US)在一个较大底部形态上方维持稳定，表现相对强势且正寻求突破。该指数今年以来上涨了3.92%，不过今天下跌了1.30%。与此同时，BTIG推荐了正突破底部形态的Datadog (DDOG.US) ，该股接连上涨，近四日已涨超7%。